Latest: FDA Approves New Biosimilar for Oncology Treatment
Healthcare Business

Renal Denervation Shows Durable Blood Pressure Benefits in Key Trials: Deepak L. Bhatt, MD, MPH, MBA

by American Journal Managed Care
0 Comments
0 Mins
Renal denervation modestly lowers blood pressure, with durable long-term benefits, according to Deepak L. Bhatt, MD, MPH, MBA.
Tags:
American Journal Managed Care
Author

American Journal Managed Care

Previous Post
Tirzepatide leads to greater weight loss than semaglutide among adults with obesity
Next Post
Analyzing Zorevunersen in Phase 3 Registrational Study for Dravet Syndrome: The EMPEROR Trial
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago